Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019

This report updates the 2009 recommendations from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States. The report summarizes data on estimated efficacy in humans using a correlates of protection model and safety data and provides updated guidance for use of anthrax vaccine adsorbed for preexposure prophylaxis.

Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge

Researchers studied the onset of protection from Anthrax Vaccine Absorbed (AVA) post-exposure prophylaxis (PEP) vaccination and to assess the potential for shortening the duration of treatment.

Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults

This article covers antimicrobial post exposure prophylaxis and antimicrobial and antitoxin treatment options. Additionally, it describes potentially beneficial critical care measures for persons with anthrax.